Health
Personalised cancer vaccine expected to be approved next year
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected
News
Advertisement
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected
There has been a lack of clarity over the risks of covid-19 and vaccines against it during pregnancy throughout much of the pandemic, with research now overwhelmingly supporting that pregnant people get vaccinated